These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2414196)

  • 1. [Study of functional domain structures on human DR determinants with mouse hybridoma antibody Tyn B1].
    Nagayoshi T
    Fukuoka Igaku Zasshi; 1985 Jun; 76(6):306-16. PubMed ID: 2414196
    [No Abstract]   [Full Text] [Related]  

  • 2. [IPO-10 monoclonal antibodies to the human B-lymphocyte differentiation antigen].
    Sidorenko SP; Vetrova EP; Berdova AG; Shlapatskaia LN; Evsev'eva AI
    Eksp Onkol; 1988; 10(3):42-4. PubMed ID: 2457482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IA mutant functional antigen-presenting cell lines.
    Glimcher LH; Hamano T; Asofsky R; Sachs DH; Pierres M; Samelson LE; Sharrow SO; Paul WE
    J Immunol; 1983 May; 130(5):2287-94. PubMed ID: 6300242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a monoclonal antibody recognizing a monomorphic determinant of DR antigens.
    Schütt C; Horejsi V; Walzel H; Siegl E
    Biomed Biochim Acta; 1989; 48(4):359-63. PubMed ID: 2473743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody to a formaldehyde-resistant epitope on the nonpolymorphic constant part of the HLA-DR antigens.
    Sorg C; Bröcker EB; Zwadlo G; Redmann K; Feige U; Ax W; Feller AC
    Transplantation; 1985 Jan; 39(1):90-3. PubMed ID: 2578237
    [No Abstract]   [Full Text] [Related]  

  • 7. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of two anti-HLA-DR-like monoclonal antibodies.
    Nikolova EB
    Haematologia (Budap); 1986; 19(2):133-40. PubMed ID: 2428703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against human leucocyte antigens. I. Antibodies against beta-2-microglobulin, immunoglobulin kappa light chains, HLA-DR-like antigens, T8 antigen, T1 antigen, a monocyte antigen, and a pan-leucocyte antigen.
    Horejsí V; Hilgert I; Kristofová H; Bazil V; Bukovský A; Kulhánková J
    Folia Biol (Praha); 1986; 32(1):12-25. PubMed ID: 2422063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of class II MHC molecules in the activation of class I-reactive T cell hybridomas.
    Minami M; Nariuchi H; Kawasaki H; Dorf ME
    J Immunol; 1986 May; 136(9):3341-5. PubMed ID: 2420887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal antibodies to RPMI-1788 lymphoblastoid line cells].
    Pinchuk VG; Sidorenko SP; Vetrova EP; Berdova AG; Shlapatskaia LN
    Eksp Onkol; 1986; 8(6):41-6. PubMed ID: 3026773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
    White J; Haskins KM; Marrack P; Kappler J
    J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human HLA-DR antigens are encoded by multiple beta-chain loci.
    Hurley CK; Nunez G; Winchester R; Finn OJ; Levy R; Capra JD
    J Immunol; 1982 Nov; 129(5):2103-8. PubMed ID: 6811658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human ia alloantigens.
    Adams TE; Bodmer JG; Bodmer WF
    Immunology; 1983 Dec; 50(4):613-24. PubMed ID: 6197354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR.
    Gonwa TA; Picker LJ; Raff HV; Goyert SM; Silver J; Stobo JD
    J Immunol; 1983 Feb; 130(2):706-11. PubMed ID: 6184401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SFR3-DR5, a monoclonal antibody with HLA-DR5 specificity.
    Radka SF; Machamer C; Cresswell P; Kostyu DD; Ward FE; Amos DB
    J Immunol; 1983 Apr; 130(4):1863-6. PubMed ID: 6187822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.